Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend or template update. This update does not modify the study content or user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-06-28T08:45:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment heading; the old Intervention / Treatment label and the previous Revision note (Revision: v3.5.5) were removed, aligning with the new v3.6.0 revision.
    Difference
    0.5%
    Check dated 2026-06-13T18:05:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision label on the page changes from v3.5.4 to v3.5.5. This reflects a metadata/version update and does not alter the visible content.
    Difference
    0.1%
    Check dated 2026-06-06T14:11:51.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision label (v3.5.4) replaces the previous v3.5.3, indicating a backend or display update without changing the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-05-15T23:49:33.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a platform/version update without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T16:51:32.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:39:21.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.